Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients
Introduction: The severity and clinical outcome of COVID-19 depend on virus-specific factors and the host's inflammatory response. Identifying biomarkers of severe COVID-19 is a crucial condition and predicts disease severity. Methodology: This study enrolled a total of 167 patients with COVID-19...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
The Journal of Infection in Developing Countries
2024-05-01
|
| Rangatū: | Journal of Infection in Developing Countries |
| Ngā marau: | |
| Urunga tuihono: | https://jidc.org/index.php/journal/article/view/18537 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|